FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

373400000: Nuclear pleomorphism, grade 3: Markedly pleomorphic nuclei, usually >2.5 red blood cell diameters, with coarse chromatin and multiple nucleoli (finding)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
1211882018 Nuclear pleomorphism, grade 3: Markedly pleomorphic nuclei, usually >2.5 RBC diameters, with coarse chromatin and multiple nucleoli en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) IPS terminology module (core metadata concept)
2970256017 Nuclear pleomorphism, grade 3: Markedly pleomorphic nuclei, usually >2.5 red blood cell diameters, with coarse chromatin and multiple nucleoli en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) IPS terminology module (core metadata concept)
2970757010 Nuclear pleomorphism, grade 3: Markedly pleomorphic nuclei, usually >2.5 red blood cell diameters, with coarse chromatin and multiple nucleoli (finding) en Fully specified name Active Only initial character case insensitive (core metadata concept) IPS terminology module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nuclear pleomorphism, grade 3: Markedly pleomorphic nuclei, usually >2.5 RBC diameters, with coarse chromatin and multiple nucleoli Is a Nuclear pleomorphism finding (finding) true Inferred relationship Some
Nuclear pleomorphism, grade 3: Markedly pleomorphic nuclei, usually >2.5 RBC diameters, with coarse chromatin and multiple nucleoli Interprets Histopathology test (procedure) true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

International Patient Summary

Back to Start